WuXiPRA, the joint venture set up earlier this year to provide Phase I-IV clinical-trial services to clients of WuXi PharmaTech and PRA in China, Hong Kong and Macau, has appointed the former head of ...
Omnicare Clinical Research, a leading global, full-service contract research organization (CRO), announces the re-branding of the company under the name Theorem Clinical Research. The brand launch ...
US-based contract research organisation (CRO) Omnicare Clinical Research has underlined its break with its former parent earlier this year by rebranding as Theorem Clinical Research. US-based contract ...
WuXi PharmaTech ($WX) and PRA believe they have a bright future in China together, and they've picked up the founding CEO of Theorem Clinical Research to lead them ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results